[Value in pulmonary diseases of a new broad spectrum semi-synthetic penicillin: amoxicillin].
D000588:Amines / Q000627:therapeutic use; D000667:Ampicillin / Q000627:therapeutic use; D001419:Bacteria / Q000302:isolation & purification; D001424:Bacterial Infections / Q000188:drug therapy*; D001980:Bronchi / Q000378:metabolism; D001991:Bronchitis / Q000188:drug therapy; D002511:Cephalosporins / Q000627:therapeutic use; D002701:Chloramphenicol / Q000627:therapeutic use; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004247:DNA / Q000032:analysis; D005340:Fibrinogen / Q000032:analysis; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000032:analysis; D007958:Leukocyte Count; D009093:Mucus / Q000378:metabolism; D010406:Penicillins / Q000627:therapeutic use*; D012008:Recurrence; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D012463:Saliva / Q000032:analysis / Q000382:microbiology; D013752:Tetracycline / Q000627:therapeutic use
D000588:Amines; D002511:Cephalosporins; D010406:Penicillins; D002701:Chloramphenicol; D000667:Ampicillin; D005340:Fibrinogen; D004247:DNA; D007770:L-Lactate Dehydrogenase; D013752:Tetracycline
Intérêt en pneumologie d'une nouvelle pénicilline semi-synthétique à large spectre: l'amoxicilline.